Disclosures

The GWG and SRG reported the following disclosures during development and approval of this guideline:

Dr. Keepers is employed as Professor and Chair of the Department of Psychiatry by Oregon Health & Science University. He receives travel funds from the American Board of Psychiatry and Neurology, the American College of Psychiatry, and the Accreditation Council for Graduate Medical Education related to his activities as a member or chair of various committees. He reports no conflicts of interest with his work on this guideline.

Dr. Fochtmann is employed as a SUNY Distinguished Service Professor of Psychiatry, Pharmacological Sciences, and Biomedical Informatics at Stony Brook University and Deputy Chief Medical Information Officer for Stony Brook Medicine. She also consults for the American Psychiatric Association on the development of practice guidelines. She reports no conflicts of interest with her work on this guideline.

Dr. Anzia is employed as Professor of Psychiatry and Behavioral Sciences and Residency Program Director/Vice Chair for Education at Northwestern University/Feinberg School of Medicine. She receives part of her salary from the Medical Staff Office of Northwestern Medicine for her role as Physician Health Liaison. Dr. Anzia receives travel funds from the American Board of Psychiatry and Neurology, the American College of Psychiatry, and the Accreditation Council for Graduate Medical Education for her activities as Board Director, committee chair, and various other committees. She has no conflicts of interest with her work on this guideline.

Dr. Benjamin is employed as Vice Chair for Education in Psychiatry at the University of Massachusetts T. H. Chan School of Medicine, where he is also Director of Neuropsychiatry and Professor of Psychiatry and Neurology. He periodically receives honoraria for lectures, provides consultation to the Massachusetts Department of Mental Health, and serves as an expert witness on neuropsychiatric issues. He is a partner in and author for Brain Educators, LLC, a publisher of educational materials designed to improve neuropsychiatric assessment skills. Any income received is used to offset production and development costs of the materials. He is a psychiatry director of the American Board of Psychiatry and Neurology and receives a stipend in connection with this work. He reports no conflicts of interest with his work on this guideline.

Dr. Lyness is employed as President and Chief Executive Officer of the American Board of Psychiatry and Neurology. He has an unpaid position as Professor Emeritus of Psychiatry at the University of Rochester School of Medicine & Dentistry. Previously, he was employed as Senior Associate Dean for Academic Affairs and Professor of Psychiatry and Neurology in the School of Medicine & Dentistry at the University of Rochester Medical Center, received compensation as a Psychiatry Director of the American Board of Psychiatry and Neurology, and provided independent medical examinations for various attorneys. He is a paid contributor to several articles for UpToDate, Inc. He has no other relevant financial or fiduciary interests and reports no conflicts of interest with his work on this guideline.

Dr. Mojtabai is employed as Professor of Public Health at Johns Hopkins Bloomberg School of Public Health with joint appointment in the Department of Psychiatry and Behavioral Sciences in Baltimore, Maryland, and as a psychiatrist at Johns Hopkins Hospital. He has been a principal investigator and co-investigator on grants funded by the National Institutes of Health. During the period of working on this guideline, he received royalties from UpToDate, Inc., and provided research consultation to Surgo Ventures as well as expert consultation regarding social media litigation on behalf of the plaintiffs. He reports no conflicts of interest with his work on this guideline.

Dr. Servis is employed as Professor of Psychiatry and Behavioral Sciences and the Vice Dean for Medical Education at the University of California Davis School of Medicine. He consults to the Medical Board of California and serves on the Psychiatry Residency in Training Examination Editorial Board for the American College of Psychiatrists and the Interdisciplinary Review Committee for the USMLE Step 2 Examination for the National Board of Medical Examiners. He reports no conflicts of interest with his work on this guideline.

Dr. Choi-Kain is employed as the Director of the Gunderson Personality Disorders Institute at McLean Hospital as well as an Assistant Professor of Psychiatry at Harvard Medical School. The Gunderson Personality Disorders Institute has a training division, providing formal training in evidence-based treatments, consultations to teams, training of trainers, and supervision of clinicians using these treatments. Dr. Choi-Kain receives payments via McLean Hospital from government agencies in Canada, Australia, Sweden, and others for teaching. The other part of the institute is a research laboratory through which Dr. Choi-Kain receives funding from private funds as well as the National Alliance for Research on Schizophrenia & Depression/Brain & Behavior Research Foundation. She receives royalties from the sales of books on BPD, especially GPM books from Springer and American Psychiatric Association Publishing. Her conflicts of interest with her work on this guideline include her work with GPM, which has been informed by prior guidelines and will incorporate any changed guidelines.

Dr. Nelson is employed as Associate Professor of Psychiatry and Behavioral Sciences and Associate Designated Institutional Official at the University of Minnesota Medical School. Dr. Nelson receives educational research grant support and travel funds from the American Board of Psychiatry and Neurology. Other sources of financial income include honoraria from universities and health systems for providing grand rounds presentations on the topic of BPD and other topics. Dr. Nelson has been compensated for providing consultative services in psychiatric education leadership and administration. Dr. Nelson receives royalties from UpToDate, Inc., and from Oxford University Press. Dr. Nelson receives royalties from Oxford University Press for co-editing a book on the topic of schizophrenia. Dr. Nelson has not received financial support from the pharmaceutical or medical device industry and reports no conflicts of interest with her work on this guideline.

Dr. Sharp is the John and Rebecca Moores Professor and Associate Dean for Faculty and Research in the Psychology Department and clinical program at the University of Houston. She is also the director of the Developmental Psychopathology Lab and the Adolescent Diagnosis Assessment Prevention and Treatment (ADAPT) Center at the University of Houston. Dr. Sharp received funding from the National Institute of Mental Health and National Institute of Child Health and Human Development for several grants on which she is the principal investigator (1R01MH127060-02, 1R01HD102436-01A1, R21MH128570), co-investigator (1R01 MH129354-01, 1I01 CX002135-01A1), faculty sponsor (1F31HD108859-01A1, 1F31MH123127-01A1), or consultant (R21 MH125052-01A1). She received honoraria for providing grand rounds and other types of educational activities related to her expertise in the developmental aspect of personality pathology. She receives royalties from Springer, American Psychiatric Association, Routledge, MIT Press, and Guilford for books on the topic of personality pathology and related pathology and/or caregiving. She is editor of Personality and Mental Health, associate editor of Personality Disorders: Theory, Research and Treatment, and section editor for Borderline Personality Disorder and Emotion Dysregulation.

Dr. Degenhardt is a child and adolescent psychiatrist employed by the Fraser Health Authority specializing in emergency psychiatry and early psychosis. She is also a clinical instructor at the University of British Columbia. During the period of preparation of this guideline, she was employed by Vancouver Coastal Health as she completed her child and adolescent subspecialty training. She reports no conflicts of interest with her work on this guideline.

Dr. Oldham is a Distinguished Emeritus Professor at Baylor College of Medicine and a senior consultant at The Menninger Clinic. He serves as editor for the Journal of Psychiatric Practice, co-editor for the Journal of Personality Disorders, and joint Editor-in-Chief for Borderline Personality Disorder and Emotion Dysregulation. He is an officer of NPSP25, LLC, and a member of the Academic Advisory Board for Silver Hill Hospital. He reports no conflicts of interest with his work on this guideline.